D. Gouet

3.3k total citations
39 papers, 555 citations indexed

About

D. Gouet is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, D. Gouet has authored 39 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in D. Gouet's work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (16 papers) and Diabetes and associated disorders (7 papers). D. Gouet is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Treatment and Management (16 papers) and Diabetes and associated disorders (7 papers). D. Gouet collaborates with scholars based in France, United States and Denmark. D. Gouet's co-authors include Pièrre Aucouturier, Liana K. Billings, Ankur Doshi, Nikolaοs Tentolouris, Helena W. Rodbard, Natalie Halladin, Randi Grøn, Esteban Jódar, J L Preud'homme and P. Fontaine and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

D. Gouet

35 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Gouet France 9 351 131 127 97 60 39 555
Lone Troelsen Denmark 11 229 0.7× 83 0.6× 113 0.9× 76 0.8× 141 2.4× 19 479
Maria Leontsini Greece 13 117 0.3× 78 0.6× 116 0.9× 26 0.3× 52 0.9× 28 488
Burkhard Tönshoff Germany 9 239 0.7× 105 0.8× 46 0.4× 50 0.5× 17 0.3× 9 463
Toshio Mukuta Japan 13 444 1.3× 90 0.7× 95 0.7× 147 1.5× 141 2.4× 28 671
A Krivitzky France 9 115 0.3× 36 0.3× 78 0.6× 23 0.2× 45 0.8× 32 315
Satoru Ogahara Japan 13 57 0.2× 51 0.4× 42 0.3× 18 0.2× 57 0.9× 26 305
Rizk Elbaz Egypt 12 51 0.1× 66 0.5× 48 0.4× 41 0.4× 46 0.8× 31 320
E.N. Ehrenfeld Israel 11 55 0.2× 146 1.1× 74 0.6× 57 0.6× 78 1.3× 22 353
Christine Azéma France 8 52 0.1× 40 0.3× 100 0.8× 14 0.1× 141 2.4× 13 350
Neeraj Das India 11 64 0.2× 28 0.2× 77 0.6× 34 0.4× 99 1.6× 25 350

Countries citing papers authored by D. Gouet

Since Specialization
Citations

This map shows the geographic impact of D. Gouet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gouet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gouet more than expected).

Fields of papers citing papers by D. Gouet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gouet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gouet. The network helps show where D. Gouet may publish in the future.

Co-authorship network of co-authors of D. Gouet

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gouet. A scholar is included among the top collaborators of D. Gouet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gouet. D. Gouet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picard, Sylvie, Jean‐Pierre Riveline, Jean‐Baptiste Julla, et al.. (2025). Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study. Diabetes & Metabolism. 51(4). 101647–101647.
2.
Kessler, Laurence, Charles Thivolet, Alfred Penfornis, et al.. (2024). Advanced Hybrid Closed Loop Algorithm Use in Type 1 Diabetes: The French MiniMed™ Glycemic Control and Quality of Life Study. Diabetes Therapy. 16(3). 413–427. 2 indexed citations
3.
Amadou, Coralie, V. Melki, Jean Pierre Allain, et al.. (2023). Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study. PLoS ONE. 18(8). e0289684–e0289684. 1 indexed citations
4.
Reach, Gérard, Pierre‐Yves Benhamou, Brigitte Delemer, et al.. (2022). An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients’ Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes. Patient Preference and Adherence. Volume 16. 1333–1350. 4 indexed citations
5.
Gouet, D., et al.. (2022). Benefits and warnings after one year of Minimed 780 G hybrid closed loop pump treatment in type 1 diabetes adults. SHILAP Revista de lepidopterología. 8. 100110–100110. 1 indexed citations
6.
Saulnier, Pierre‐Jean, Claire Briet, Elise Gand, et al.. (2019). No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study. Journal of Diabetes and its Complications. 33(8). 554–560. 8 indexed citations
7.
8.
Roussel, Ronan, P. Fontaine, D. Gouet, et al.. (2018). Le traitement du diabète de type 2 en France est dynamique plutôt qu’inerte : analyse des prescriptions de 847 122 patients. Médecine des Maladies Métaboliques. 12(4). 346–352. 4 indexed citations
9.
Hanaire, H., C. Attali, D. Gouet, et al.. (2016). [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization].. PubMed. 28(6). 781–789. 4 indexed citations
10.
Cariou, Bertrand, P. Fontaine, É. Eschwège, et al.. (2014). Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study. Diabetes & Metabolism. 41(2). 116–125. 100 indexed citations
11.
12.
Kerlan, V., D. Gouet, Michel Marre, & Éric Renard. (2013). Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal–bolus therapy in type 1 and type 2 diabetes. Annales d Endocrinologie. 74(5-6). 487–490. 3 indexed citations
13.
Gouet, D., É. Eschwège, Alfred Penfornis, et al.. (2013). PO45 Facteurs prédictifs des hypoglycémies chez les diabétiques de type 1 et de type 2 insulino-traités en France : Analyse de l’étude DIALOG. Diabetes & Metabolism. 39. A31–A31.
14.
Paccalin, Marc, D. Gouet, Vincent Delwail, et al.. (2001). Lymphome malin primitif de la thyroïde : à propos de huit cas. La Revue de Médecine Interne. 22(10). 934–938. 1 indexed citations
15.
Preud'homme, J L, D. Gouet, F Danon, et al.. (1988). Isotypic distribution of anti-double-stranded DNA antibodies: a diagnostic evaluation by enzyme-linked immunosorbent assay.. PubMed. 5(5). 256–61. 15 indexed citations
16.
Gouet, D., et al.. (1984). [Association of Vogt-Koyanagi disease, Gougerot-Sjögren syndrome and erythema nodosum].. PubMed. 13(10). 624–624. 3 indexed citations
17.
Gouet, D., et al.. (1984). [Chronic atrophic polychondritis. Critical analysis of the therapeutic efficacy of dapsone. 2 cases].. PubMed. 13(12). 723–6. 5 indexed citations
18.
Gouet, D., et al.. (1982). Rechutes itératives d'amibiase hépatique avec échec du traitement par le métronidazole.. ˜La œNouvelle presse médicale. 11(45). 3349–3349. 1 indexed citations
19.
Gouet, D., et al.. (1982). [Nephrotic syndrome associated with chronic lymphoid leukemia. Review of the literature apropos of a case].. PubMed. 11(41). 3047–9. 2 indexed citations
20.
Abadie, J., et al.. (1982). Pancréas artificiel et pompe à insuline portable dans le diabète insulino-dépendant incipiens de l'adulte jeune: rémissions induites. La Revue de Médecine Interne. 3(4). 313–319. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lone Troelsen Breakdown of academic impact, for papers by Maria Leontsini Breakdown of academic impact, for papers by Burkhard Tönshoff Breakdown of academic impact, for papers by Toshio Mukuta Breakdown of academic impact, for papers by A Krivitzky Breakdown of academic impact, for papers by Satoru Ogahara Breakdown of academic impact, for papers by Rizk Elbaz Breakdown of academic impact, for papers by E.N. Ehrenfeld Breakdown of academic impact, for papers by Christine Azéma Breakdown of academic impact, for papers by Neeraj Das
Rankless by CCL
2026